Cargando…
Syndrome respiratoire aigu sévère : une épidémie singulière de pneumonie virale
INFECTIOUS AGENT: The severe acute respiratory syndrome (SARS) is a febrile pneumonia initially observed in China at the end of 2002. The infectious agent has rapidly been identified as a new coronavirus, baptised SARS-associated coronavirus (CoV-SARS). Transmission is inter-human, via respiratory p...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135803/ https://www.ncbi.nlm.nih.gov/pubmed/15041887 http://dx.doi.org/10.1016/S0755-4982(04)98581-8 |
_version_ | 1783518138422263808 |
---|---|
author | Guihot, Amélie Bricaire, François Li, Taisheng Bossi, Philippe |
author_facet | Guihot, Amélie Bricaire, François Li, Taisheng Bossi, Philippe |
author_sort | Guihot, Amélie |
collection | PubMed |
description | INFECTIOUS AGENT: The severe acute respiratory syndrome (SARS) is a febrile pneumonia initially observed in China at the end of 2002. The infectious agent has rapidly been identified as a new coronavirus, baptised SARS-associated coronavirus (CoV-SARS). Transmission is inter-human, via respiratory particles mainly. CLINICAL PRESENTATION AND TREATMENT: The clinical presentation is highly variable, from a mild fever to an acute respiratory distress syndrome. There is no specific treatment. Ribavirin associated with steroids have been used with success in numerous cases. EPIDEMIOLOGY: During the first half of 2003, the spreading of the virus has been very fast, with a pandemic mode of evolution. More than 8 000 people were infected and 774 died. The reservoir of the virus, which may be animal, is still unknown. The epidemic seems to be controlled, but sporadic or epidemic re-emergences may occur and have been observed in China duting January 2004. |
format | Online Article Text |
id | pubmed-7135803 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2004 |
publisher | Elsevier Masson SAS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71358032020-04-08 Syndrome respiratoire aigu sévère : une épidémie singulière de pneumonie virale Guihot, Amélie Bricaire, François Li, Taisheng Bossi, Philippe Presse Med Article INFECTIOUS AGENT: The severe acute respiratory syndrome (SARS) is a febrile pneumonia initially observed in China at the end of 2002. The infectious agent has rapidly been identified as a new coronavirus, baptised SARS-associated coronavirus (CoV-SARS). Transmission is inter-human, via respiratory particles mainly. CLINICAL PRESENTATION AND TREATMENT: The clinical presentation is highly variable, from a mild fever to an acute respiratory distress syndrome. There is no specific treatment. Ribavirin associated with steroids have been used with success in numerous cases. EPIDEMIOLOGY: During the first half of 2003, the spreading of the virus has been very fast, with a pandemic mode of evolution. More than 8 000 people were infected and 774 died. The reservoir of the virus, which may be animal, is still unknown. The epidemic seems to be controlled, but sporadic or epidemic re-emergences may occur and have been observed in China duting January 2004. Elsevier Masson SAS. 2004-03 2008-01-03 /pmc/articles/PMC7135803/ /pubmed/15041887 http://dx.doi.org/10.1016/S0755-4982(04)98581-8 Text en Copyright © 2004 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Guihot, Amélie Bricaire, François Li, Taisheng Bossi, Philippe Syndrome respiratoire aigu sévère : une épidémie singulière de pneumonie virale |
title | Syndrome respiratoire aigu sévère : une épidémie singulière de pneumonie virale |
title_full | Syndrome respiratoire aigu sévère : une épidémie singulière de pneumonie virale |
title_fullStr | Syndrome respiratoire aigu sévère : une épidémie singulière de pneumonie virale |
title_full_unstemmed | Syndrome respiratoire aigu sévère : une épidémie singulière de pneumonie virale |
title_short | Syndrome respiratoire aigu sévère : une épidémie singulière de pneumonie virale |
title_sort | syndrome respiratoire aigu sévère : une épidémie singulière de pneumonie virale |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135803/ https://www.ncbi.nlm.nih.gov/pubmed/15041887 http://dx.doi.org/10.1016/S0755-4982(04)98581-8 |
work_keys_str_mv | AT guihotamelie syndromerespiratoireaigusevereuneepidemiesingulieredepneumonievirale AT bricairefrancois syndromerespiratoireaigusevereuneepidemiesingulieredepneumonievirale AT litaisheng syndromerespiratoireaigusevereuneepidemiesingulieredepneumonievirale AT bossiphilippe syndromerespiratoireaigusevereuneepidemiesingulieredepneumonievirale |